North Chem: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
North Chem
Largest movements
- Receivables within one year -€238,992
down €238,992 (-33.8%), from €707,626 to €468,634
of which Trade receivables: -€300,970
- Cash +€16,645
up €16,645 (+266%), from €6,252 to €22,897
mainly Receivables within one year (+€238,992) and Other debts (+€34,000)
- Trade debts -€231,140
down €231,140 (-34.2%), from €674,880 to €443,740
- Other debts +€34,000
new in 2026: €34,000
- Profit (loss) carried forward -€21,968
down €21,968 (-97.8%), from €22,457 to €490
- Other operating charges +€10,332
new in 2026: €10,332
- Gross operating margin -€3,610
down €3,610 (-11.9%), from €30,254 to €26,643
- Taxes -€3,230
down €3,230 (-43.2%), from €7,486 to €4,256
- Financial income +€954
new in 2026: €954
- Depreciation +€635
up €635 (+204%), from €310 to €945
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €714,823 | €492,485 | -€222,338 | -31.1% |
| Formation expenses | 20 | €945 | - | -€945 | |
| Current assets | 29/58 | €713,878 | €492,485 | -€221,393 | -31.0% |
| Amounts receivable within one year | 40/41 | €707,626 | €468,634 | -€238,992 | -33.8% |
| Trade receivables | 40 | €707,050 | €406,080 | -€300,970 | -42.6% |
| Other amounts receivable | 41 | €576 | €62,554 | +€61,978 | +10,754% |
| Cash at bank and in hand | 54/58 | €6,252 | €22,897 | +€16,645 | +266% |
| Deferred charges and accrued income | 490/1 | - | €954 | +€954 | |
| Total equity and liabilities | 10/49 | €714,823 | €492,485 | -€222,338 | -31.1% |
| Equity | 10/15 | €32,457 | €10,490 | -€21,968 | -67.7% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €22,457 | €490 | -€21,968 | -97.8% |
| Amounts payable | 17/49 | €682,366 | €481,996 | -€200,370 | -29.4% |
| Amounts payable within one year | 42/48 | €682,366 | €481,996 | -€200,370 | -29.4% |
| Trade debts | 44 | €674,880 | €443,740 | -€231,140 | -34.2% |
| Suppliers | 440/4 | €674,880 | €443,740 | -€231,140 | -34.2% |
| Taxes, remuneration and social security | 45 | €7,486 | €4,256 | -€3,230 | -43.2% |
| Taxes | 450/3 | €7,486 | €4,256 | -€3,230 | -43.2% |
| Other amounts payable | 47/48 | - | €34,000 | +€34,000 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €310 | €945 | +€635 | +204% |
| Other operating charges | 640/8 | - | €10,332 | +€10,332 | |
| Gross operating margin | 9900 | €30,254 | €26,643 | -€3,610 | -11.9% |
| Operating profit (loss) | 9901 | €29,943 | €15,366 | -€14,577 | -48.7% |
| Financial income | 75/76B | - | €954 | +€954 | |
| Recurring financial income | 75 | - | €954 | +€954 | |
| Financial charges | 65/66B | - | €33 | +€33 | |
| Recurring financial charges | 65 | - | €33 | +€33 | |
| Profit (loss) for the period before taxes | 9903 | €29,943 | €16,288 | -€13,655 | -45.6% |
| Income taxes | 67/77 | €7,486 | €4,256 | -€3,230 | -43.2% |
| Profit (loss) for the period | 9904 | €22,457 | €12,032 | -€10,425 | -46.4% |
| Profit (loss) for the period to be appropriated | 9905 | €22,457 | €12,032 | -€10,425 | -46.4% |
Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.